• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Market Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov28
Nomura Reiterates Buy Rating on WuXi AppTec, Raises Target Price to HKD132.8
03:55
Nov26
JPMorgan Increases Holdings in WuXi Biologics Shares
11:51
WuXi Biologics Shareholder Reduces Holding to 1% Threshold
08:55
Nov25
WuXi AppTec's Q3 2025 Earnings Report Shows Significant Contribution from Non-recurring Gains
06:33
Nov13
WuXi Biologics Controlling Shareholder Plans to Reduce Shares by 2%
11:02
Nov10
BlackRock Increases Stake in Wuxi Biologics Holdings
09:08

Schedules & Filings

Schedules
Filings
Oct26
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 12.04 B, Net Income 3.515 B, EPS 1.2083

Sep26
Distribution Plan(CST)

Cash dividend 0.35 CNY

Distribution Plan(CST)

Cash dividend 0.35 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More